文献

J-GLOBAL ID：201602212966414830   整理番号：16A1213008

ヒト子宮内膜癌におけるヌクレオビンディン2(NUCB2):細胞増殖および遊走と関連する有力な予後因子

Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration

著者 (8件)： Takagi Kiyoshi (Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Miki Yasuhiro (Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan) ,  Tanaka Sota (Departments of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Hashimoto Chiaki (Departments of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Watanabe Mika (Department of Pathology, Tohoku University Hospital, Sendai, Japan) ,  Sasano Hironobu (Departments of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Ito Kiyoshi (Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan) ,  Suzuki Takashi (Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan)
資料名： Endocrine Journal  (Endocrine Journal)
巻： 63  号： 3  ページ： 287-299(J-STAGE)  発行年： 2016年 
JST資料番号： F0625A  ISSN： 0918-8959  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： ヌクレオビンディン2(NUCB2)はいくつかの機能的ドメイン...

シソーラス用語： ヒト ,...
準シソーラス用語： *ヌクレオビンディン2 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1213008&from=J-GLOBAL&jstjournalNo=F0625A") }}

著者キーワード (5件)： NUCB2 ,  Endometrial cancer ,  Prognosis ,  Biomarker ,  Immunohistochemistry

分類 (3件)： 腫ようの化学・生化学・病理学  (GE02030N) ,  女性生殖器と胎児の腫よう  (GS04000K) ,  生物学的機能  (EB03040U)

引用文献 (38件)：

• 1. Kato T, Watari H, Endo D, Mitamura T, Odagiri T, et al. (2012) New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system. J Surg Oncol 106: 938-941.
• 2. Lanciano RM, Greven KM (1995) Adjuvant treatment for endometrial cancer: who needs it? Gynecol Oncol 57: 135-137.
• 3. Ball HG (1996) Do we know the best therapy for early endometrial cancer? Gynecol Oncol 60: 173-175.
• 4. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, et al. (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355: 1404-1411.
• 5. Orr JW Jr, Roland PY, Leichter D, Orr PF (2001) Endometrial cancer: is surgical staging necessary? Curr Opin Oncol 13: 408-412.

タイトルに関連する用語 (5件)： ヒト ,  子宮内膜癌 ,  細胞増殖 ,  遊走 ,  予後因子